In this week's Homerun Slides, the cardiovascular outcomes of patients in the placebo vs empagliflozin study.

Insulin receptors, ligand binding: The insulin action sequence is initiated with specific binding to high-affinity receptors on the plasma membrane of target cells. The insulin receptor is a large transmembrane glycoprotein consisting of two alpha- and two beta- subunits that form a heterotetramer, as depicted in Figure 12.1. The insulin receptor is synthesized from a single gene as a polypeptide pro receptor comprised of alpha- and beta- subunit sequences in tandem.

This past Thursday, Congress passed a resolution to begin the dismantling of the Affordable Care Act. If you remember, many of the candidates, including the president-elect, touted this as their first act if they won the election. Now that they have made the first move, you have to wonder if …

Can we answer the question of how you can have a pre-disease that increases your risk of death? You either have it or you don’t!

Recent survey finds support for keeping parts of it intact, even those who want it repealed.

What does it mean when we say we need to focus on the total or whole patient?

Barrier means more work including monitoring more often and making more adjustments.

Trial shows mobile devices may be useful in future health studies.

Dr. Pam Taub talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting about her experience as a cardiologist working with diabetes patients who are often coming to her for cardiology treatment and starting diabetes treatment as well.

In the transcript of this exclusive interview, Dr. Taub discusses her experience as a cardiologist, seeing patients with various cardiac diseases, about 75% of whom have diabetes.